These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25696916)

  • 21. Hepatitis C virus (HCV) and lymphomagenesis.
    Weng WK; Levy S
    Leuk Lymphoma; 2003 Jul; 44(7):1113-20. PubMed ID: 12916862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
    Rattotti S; Ferretti VV; Rusconi C; Rossi A; Fogazzi S; Baldini L; Pioltelli P; Balzarotti M; Farina L; Ferreri AJM; Laszlo D; Speziale V; Varettoni M; Sciarra R; Morello L; Tedeschi A; Frigeni M; Defrancesco I; Zerbi C; Flospergher E; Nizzoli ME; Morra E; Arcaini L;
    Hematol Oncol; 2019 Apr; 37(2):160-167. PubMed ID: 30726562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C infection and risk of malignant lymphoma.
    Schöllkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Panum I; Vinner L; Chang ET; Glimelius B; Porwit A; Sundström C; Hansen M; Adami HO; Melbye M
    Int J Cancer; 2008 Apr; 122(8):1885-90. PubMed ID: 18271005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH.
    Nieters A; Kallinowski B; Brennan P; Ott M; Maynadié M; Benavente Y; Foretova L; Cocco PL; Staines A; Vornanen M; Whitby D; Boffetta P; Becker N; De Sanjosé S
    Gastroenterology; 2006 Dec; 131(6):1879-86. PubMed ID: 17087949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia?
    Libra M; Polesel J; Russo AE; De Re V; Cinà D; Serraino D; Nicoletti F; Spandidos DA; Stivala F; Talamini R
    Int J Oncol; 2010 Jun; 36(6):1331-40. PubMed ID: 20428756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoproliferative diseases and hepatitis C virus infection.
    Hausfater P; Rosenthal E; Cacoub P
    Ann Med Interne (Paris); 2000 Feb; 151(1):53-7. PubMed ID: 10761563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.
    Forghieri F; Luppi M; Barozzi P; Maffei R; Potenza L; Narni F; Marasca R
    Clin Dev Immunol; 2012; 2012():807351. PubMed ID: 22844326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of hepatitis C virus infection in malignant lymphoma in Spain.
    de Sanjose S; Nieters A; Goedert JJ; Domingo-Domenech E; Fernandez de Sevilla A; Bosch R; Herrera P; Domingo A; Petit J; Bosch X; Kallinowski B
    Int J Cancer; 2004 Aug; 111(1):81-5. PubMed ID: 15185347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic profiling of non-Hodgkin's lymphoma with or without hepatitis C virus infection.
    Zekri AR; Ahmed H; Ismail M; El-Nashar AT; El-Mokadem T; Hassan A
    Egypt J Immunol; 2010; 17(2):81-90. PubMed ID: 23082489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment.
    Carbone A; Gloghini A
    World J Gastroenterol; 2013 Nov; 19(44):7874-9. PubMed ID: 24307781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later.
    Mazzaro C; Tirelli U; Pozzato G
    Dig Liver Dis; 2005 Apr; 37(4):219-26. PubMed ID: 15788203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
    Nosotti L; D'Andrea M; Pitidis A; Pimpinelli F; Dessanti ML; Pisani F; Vignally P; Petti MC
    Scand J Infect Dis; 2012 Jan; 44(1):70-3. PubMed ID: 21905952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.
    Arcaini L; Merli M; Volpetti S; Rattotti S; Gotti M; Zaja F
    Clin Dev Immunol; 2012; 2012():638185. PubMed ID: 22956970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study].
    Catassi C; Fabiani E; Coppa GV; Gabrielli A; Centurioni R; Leoni P; Barbato M; Viola F; Martelli M; De Renzo A; Rotoli B; Bertolani P; Federico M; Carroccio A; Iannitto E; Baldassarre M; Guarini A; Guariso G; Favaretto G; Caramaschi P; Ambrosetti A
    Recenti Prog Med; 1998 Feb; 89(2):63-7. PubMed ID: 9558907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
    Canioni D; Michot JM; Rabiega P; Molina TJ; Charlotte F; Lazure T; Davi F; Settegrana C; Berger F; Alric L; Cacoub P; Terrier B; Suarez F; Sibon D; Dupuis J; Feray C; Tilly H; Pol S; Deau Fischer B; Roulland S; Thieblemont C; Leblond V; Carrat F; Hermine O; Besson C;
    PLoS One; 2016; 11(6):e0156384. PubMed ID: 27257992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas.
    Silvestri F; Barillari G; Fanin R; Pipan C; Falasca E; Salmaso F; Zaja F; Infanti L; Patriarca F; Botta GA; Baccarani M
    Haematologica; 1997; 82(3):314-7. PubMed ID: 9234578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group.
    Nicolosi Guidicelli S; Lopez-Guillermo A; Falcone U; Conconi A; Christinat A; Rodriguez-Abreu D; Grisanti S; Lobetti-Bodoni C; Piffaretti JC; Johnson PW; Mombelli G; Cerny A; Montserrat E; Cavalli F; Zucca E
    Hematol Oncol; 2012 Sep; 30(3):137-42. PubMed ID: 22105737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study.
    Engels EA; Chatterjee N; Cerhan JR; Davis S; Cozen W; Severson RK; Whitby D; Colt JS; Hartge P
    Int J Cancer; 2004 Aug; 111(1):76-80. PubMed ID: 15185346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.
    La Mura V; De Renzo A; Perna F; D'Agostino D; Masarone M; Romano M; Bruno S; Torella R; Persico M
    J Hepatol; 2008 Oct; 49(4):557-63. PubMed ID: 18678434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.
    El-Sayed GM; Mohamed WS; Nouh MA; Moneer MM; El-Mahallawy HA
    Egypt J Immunol; 2006; 13(1):105-14. PubMed ID: 17974155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.